Literature DB >> 1863440

'Medial maxillectomy' for lateral nasal wall neoplasms.

J D Osguthorpe1, R A Weisman.   

Abstract

Lateral rhinotomy and "medial maxillectomy," an en bloc resection of the medial maxillary sinus, ethmoid sinus with the lamina papyracea, medial orbital floor, and lacrimal fossa-duct, have been advocated for lateral nasal wall neoplasma. Experience with 35 (of 41) patients followed up at least 30 months (median, 57 months) postoperatively is reported. There was a 9% recurrence for benign tumors and 15% for malignant neoplasms, the latter only in the patients with nonmelanoma malignant neoplasms not receiving postoperative radiotherapy. The most frequent complications were cavity crusting, epicanthal scarring, and epiphora.

Entities:  

Mesh:

Year:  1991        PMID: 1863440     DOI: 10.1001/archotol.1991.01870190063013

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Outcomes of endonasal endoscopic dacryocystorhinostomy after maxillectomy in patients with paranasal sinus and skull base tumors.

Authors:  Sara Abu-Ghanem; Ran Ben-Cnaan; Igal Leibovitch; Gilad Horowitz; Gadi Fishman; Dan M Fliss; Avraham Abergel
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-20       Impact factor: 2.503

2.  Inverted Papilloma of the Maxillary Sinus: A Recurrence Analysis According to Surgical Approaches.

Authors:  Jin Youp Kim; Su Hwan Kim; Pilkeun Jang; Yuju Seo; Sung-Woo Cho; Jeong-Whun Kim; Doo Hee Han; Hyun Jik Kim; Dong-Young Kim; Chae-Seo Rhee; Tae-Bin Won
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

3.  Imaging characteristics of dacryocystocele diagnosed after surgery for sinonasal cancer.

Authors:  J M Debnam; B Esmaeli; L E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-05       Impact factor: 3.825

4.  Comparison Between Endoscopic Prelacrimal Medial Maxillectomy and Caldwell-Luc Approach for Benign Maxillary Sinus Tumors.

Authors:  Jung Joo Lee; Al-Magribi Ahmad Z; Donghyeok Kim; Gwanghui Ryu; Hyo Yeol Kim; Hun-Jong Dhong; Seung-Kyu Chung; Sang Duk Hong
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-11-22       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.